期刊文献+
共找到26,714篇文章
< 1 2 250 >
每页显示 20 50 100
Recombinant adeno-associated virus 8-mediated inhibition of microRNA let-7a ameliorates sclerosing cholangitis in a clinically relevant mouse model
1
作者 Hui Hua Qian-Qian Zhao +9 位作者 Miriam Nkesichi Kalagbor Guo-Zhi Yu Man Liu Zheng-Rui Bian Bei-Bei Zhang Qian Yu Yin-Hai Xu Ren-Xian Tang Kui-Yang Zheng Chao Yan 《World Journal of Gastroenterology》 SCIE CAS 2024年第5期471-484,共14页
BACKGROUND Primary sclerosing cholangitis(PSC)is characterized by chronic inflammation and it predisposes to cholangiocarcinoma due to lack of effective treatment options.Recombinant adeno-associated virus(rAAV)provid... BACKGROUND Primary sclerosing cholangitis(PSC)is characterized by chronic inflammation and it predisposes to cholangiocarcinoma due to lack of effective treatment options.Recombinant adeno-associated virus(rAAV)provides a promising platform for gene therapy on such kinds of diseases.A microRNA(miRNA)let-7a has been reported to be associated with the progress of PSC but the potential therapeutic implication of inhibition of let-7a on PSC has not been evaluated.AIM To investigate the therapeutic effects of inhibition of a miRNA let-7a transferred by recombinant adeno-associated virus 8(rAAV8)on a xenobiotic-induced mouse model of sclerosing cholangitis.METHODS A xenobiotic-induced mouse model of sclerosing cholangitis was induced by 0.1% 3,5-Diethoxycarbonyl-1,4-Dihydrocollidine(DDC)feeding for 2 wk or 6 wk.A single dose of rAAV8-mediated anti-let-7a-5p sponges or scramble control was injected in vivo into mice onset of DDC feeding.Upon sacrifice,the liver and the serum were collected from each mouse.The hepatobiliary injuries,hepatic inflammation and fibrosis were evaluated.The targets of let-7a-5p and downstream molecule NF-κB were detected using Western blot.RESULTS rAAV8-mediated anti-let-7a-5p sponges can depress the expression of let-7a-5p in mice after DDC feeding for 2 wk or 6 wk.The reduced expression of let-7a-5p can alleviate hepato-biliary injuries indicated by serum markers,and prevent the proliferation of cholangiocytes and biliary fibrosis.Furthermore,inhibition of let-7a mediated by rAAV8 can increase the expression of potential target molecules such as suppressor of cytokine signaling 1 and Dectin1,which consequently inhibit of NF-κB-mediated hepatic inflammation.CONCLUSION Our study demonstrates that a rAAV8 vector designed for liver-specific inhibition of let-7a-5p can potently ameliorate symptoms in a xenobiotic-induced mouse model of sclerosing cholangitis,which provides a possible clinical translation of PSC of human. 展开更多
关键词 Primary sclerosing cholangitis recombinant adeno-associated virus 8 Let-7a-5p Therapeutic effects INFLAMMATION
下载PDF
Lyophilized recombinant human brain natriuretic peptide for chronic heart failure:Effects on cardiac function and inflammation 被引量:2
2
作者 Feng Li Hao Li +2 位作者 Rong Luo Jia-Bao Pei Xue-Ying Yu 《World Journal of Clinical Cases》 SCIE 2023年第26期6066-6072,共7页
BACKGROUND Chronic heart failure(CHF)is a serious and prevalent condition characterized by impaired cardiac function and inflammation.Standard therapy for CHF has limitations,prompting the exploration of alternative t... BACKGROUND Chronic heart failure(CHF)is a serious and prevalent condition characterized by impaired cardiac function and inflammation.Standard therapy for CHF has limitations,prompting the exploration of alternative treatments.Recombinant human brain natriuretic peptide(BNP)has emerged as a potential therapy,with evidence suggesting that it can improve cardiac function and reduce inflammation in patients with CHF.However,further research is required to determine the efficacy and safety of lyophilized recombinant human BNP in CHF patients and its impact on microinflammatory status.This study aimed to investigate the effects of lyophilized recombinant human BNP therapy on CHF patients’cardiac function and microinflammatory status.AIM To investigate the effects of freeze-dried recombinant human BNP therapy on cardiac function and microinflammatory status in patients with CHF.METHODS In total,102 CHF patients admitted to our hospital from January 2021 to January 2022 were randomly assigned to control and observation groups(n=51 patients/group).The control patients were treated with standard HF therapy for 3 d,whereas the observational patients were injected with the recombinant human BNP for 3 d.Clinical efficacy,inflammatory factor levels,myocardial damage,cardiac function before and after the treatment,and adverse reactions during treatment were compared between the two groups.RESULTS The overall clinical efficacy was higher in the observation group than in the control group.Compared with baseline,serum hypersensitive C-reactive protein,N-terminal proBNP,and troponin I level,and physical,emotional,social,and economic scores were lower in both groups after treatment,with greater reductions in levels and scores noted in the observation group than in the control group.The overall incidence of adverse reactions in the observation group was not significantly different compared with that in the control group(P>0.05).CONCLUSION Freeze-dried recombinant human BNP therapy can improve heart function and enhance microinflammatory status,thereby improving overall quality of life without any obvious side effects.This therapy is safe and reliable. 展开更多
关键词 Chronic heart failure Lyophilized recombinant human brain natriuretic peptide Cardiac function Microinflammatory state
下载PDF
Xylanase improves the intestinal barrier function of Nile tilapia(Oreochromis niloticus)fed with soybean(Glycine max)meal
3
作者 Tong Wang Nannan Zhou +6 位作者 Junyi He Zhenzhen Hao Chentao Zhou Yidi Du Zhenyu Du Xiaoyun Su Meiling Zhang 《Journal of Animal Science and Biotechnology》 SCIE CAS CSCD 2023年第5期2224-2238,共15页
Background Soybean(Glycine max)meal is one of the important protein sources for fish,but the non-starch polysaccharides(NSP)in soybean meal impair the intestinal barrier function.Here we aimed to investigate whether x... Background Soybean(Glycine max)meal is one of the important protein sources for fish,but the non-starch polysaccharides(NSP)in soybean meal impair the intestinal barrier function.Here we aimed to investigate whether xylanase can alleviate the adverse effects on the gut barrier induced by soybean meal in Nile tilapia and to explore the possible mechanism.Results Nile tilapia(Oreochromis niloticus)(4.09±0.02 g)were fed with two diets including SM(soybean meal)and SMC(soybean meal+3,000 U/kg xylanase)for 8 weeks.We characterized the effects of xylanase on the gut barrier,and the transcriptome analysis was performed to investigate the underlying mechanism.Dietary xylanase improved intestinal morphology and decreased the concentration of lipopolysaccharide(LPS)in serum.The results of transcriptome and Western blotting showed that dietary xylanase up-regulated the expression level of mucin2(MUC2)which may be related to the inhibition of protein kinase RNA-like endoplasmic reticulum kinase(perk)/activating transcription factor 4(atf4)signaling pathways.Microbiome analysis showed that addition of xylanase in soybean meal altered the intestinal microbiota composition and increased the concentration of butyric acid in the gut.Notably,dietary sodium butyrate was supplemented into the soybean meal diet to feed Nile tilapia,and the data verified that sodium butyrate mirrored the beneficial effects of xylanase.Conclusions Collectively,supplementation of xylanase in soybean meal altered the intestinal microbiota composition and increased the content of butyric acid which can repress the perk/atf4 signaling pathway and increase the expression of muc2 to enhance the gut barrier function of Nile tilapia.The present study reveals the mechanism by which xylanase improves the intestinal barrier,and it also provides a theoretical basis for the application of xylanase in aquaculture. 展开更多
关键词 BUTYRATE Exogenous enzymes Intestinal health Intestinal microbiota MUCIN xylanase
下载PDF
Expression and Evaluation of Wb-SXP-1 and Wb-123 Recombinant Antigens as Potential Diagnostic Biomarkers for Lymphatic Filariasis
4
作者 Sharlene Kerubo Mageto Rebecca Wanjiku Waihenya +11 位作者 Anne Wanjiru Mwangi Peter Kipkemboi Rotich Matthew Mutinda Munyao Tonny Teya Robinson Mugasiali Irekwa Joanne Jepkemei Yego Caroline Wangui Njoroge Grace Ng’endo Kanyita Nicole Sian Tanchu Dawala Koromtili Oumar Primrose Muthoni Ndungu Samson Muuo Nzou 《American Journal of Molecular Biology》 CAS 2023年第2期95-112,共18页
Lymphatic filariasis (LF) remains a public health concern as it can cause permanent morbidity and disability to those infected. While the global elimination of LF in these endemic areas is ongoing through mass drug ad... Lymphatic filariasis (LF) remains a public health concern as it can cause permanent morbidity and disability to those infected. While the global elimination of LF in these endemic areas is ongoing through mass drug administration, there is the need to develop diagnostic tools that would be utilized to track the progress of total global eradication as well as perform surveillance for the recurrence of lymphatic filariasis transmission. Currently, approved LF diagnosis tools are faced with lack of specificity, low sensitivity, and periodicity dependence. Recombinant filarial antigen-based assays can address these drawbacks and offer practical instruments for LF diagnosis and surveillance. This present study, evaluated rWb-SXP-1 and rWb-123 antigens as potential diagnostic biomarker tools for Wuchereria banchrofti in human sera using microspheres-based multiplex serological assay. Based on statistical analysis using XLSTAT 2019 (Addinsoft) on data generated from multiplex technology assay, generated ROC curves for both rWb-SXP-1 and rWb-123 demonstrated 87.1% sensitivity to Wuchereria banchrofti human sera with rWb-SXP-1 antigens having the highest specificity of 96%. Indication that rWb-SXP-1 and rWb-123 antigens are capable of detecting immunoglobulin G4 (IgG4) antibodies in human sera synthesized specifically against W. banchrofti infections. Therefore, rWb-SXP-1 and rWb-123 antigens can be utilized to detect W. banchrofti infections by antibody profiling with excellent diagnostic sensitivity and specificity using microsphere-based multiplex serological tests. This method can be particularly practical for screening a large number of sera samples and/or for quick, extensive field-testing due to the high-throughput and quick formats applied. 展开更多
关键词 Lymphatic Filariasis recombinant Antigens DIAGNOSIS
下载PDF
Tensile Properties and Prediction Model of Recombinant Bamboo at Different Temperatures
5
作者 Kunpeng Zhao Yang Wei +2 位作者 Si Chen Kang Zhao Mingmin Ding 《Journal of Renewable Materials》 SCIE EI 2023年第6期2695-2712,共18页
The destruction of recombinant bamboo depends on many factors,and the complex ambient temperature is an important factor affecting its basic mechanical properties.To investigate the failure mechanism and stress–strai... The destruction of recombinant bamboo depends on many factors,and the complex ambient temperature is an important factor affecting its basic mechanical properties.To investigate the failure mechanism and stress–strain relationship of recombinant bamboo at different temperatures,eighteen tensile specimens of recombinant bamboo were tested.The results showed that with increasing ambient temperature,the typical failure modes of recombinant bamboo were flush fracture,toothed failure,and serrated failure.The ultimate tensile strength,ultimate strain and elastic modulus of recombinant bamboo decreased with increasing temperature,and the ultimate tensile stress decreased from 154.07 to 96.55 MPa,a decrease of 37.33%,and the ultimate strain decreased from 0.011 to 0.008,a decrease of 26.57%.Based on the Ramberg-Osgood model and the pseudo‒elastic design method,a predictive model was established for the tensile stress–strain relationship of recombinant bamboo considering the temperature level.The model can accurately evaluate the tensile stress–strain relationship of recombinant bamboo under different temperature conditions. 展开更多
关键词 recombinant bamboo TEMPERATURE tensile behaviour stress-strain relationship predictive model
下载PDF
Lyophilized recombinant human brain natriuretic peptide: A promising therapy in patients with chronic heart failure
6
作者 Christos Kourek Alexandros Briasoulis +2 位作者 Grigorios Giamouzis John Skoularigis Andrew Xanthopoulos 《World Journal of Clinical Cases》 SCIE 2023年第36期8603-8605,共3页
Lyophilized recombinant brain natriuretic peptide(BNP)is an exogenous peptide synthesized by artificial recombination technology,with a similar structure and similar physiological effects with the endogenous natriuret... Lyophilized recombinant brain natriuretic peptide(BNP)is an exogenous peptide synthesized by artificial recombination technology,with a similar structure and similar physiological effects with the endogenous natriuretic peptide secreted by the human body.It’s main mechanism of action is to increase cyclic guanosine monophosphate by binding with its corresponding receptor in the body,regulating,thus,the imbalance of the vascular system and cardiac hemodynamics,improving the heart’s pumping capacity,and inhibiting sympathetic excitability and myocardial remodeling.Moreover,it can promote mitochondrial metabolism and enhance the use of adenosine triphosphate in cardiomyocytes.In the present study,102 chronic heart failure(HF)patients were randomly assigned to a control and an observation group consisting of 51 patients each.Patients of the control group were treated with standard HF therapy for 3 d including oral metoprolol tartrate tablets,spironolactone,and olmesartanate while patients of the observation group were administered the recombinant human BNP injection for the same time-period,plus the standard HF therapy.The recombinant human BNP group(observation group)demonstrated better physical,emotional,social,and economic scores,as well as cardiac and inflammatory biomarkers such as serum hypersensitive C-reactive protein,N-terminal pro BNP and troponin I levels,compared to the control group.Moreover,cardiac function was also improved,as left ventricular ejection fraction and stroke volume were significantly higher in the observation group than in the control group.Interestingly,adverse reactions were not different between the 2 groups.However,these results are not generalizable and the need of large multicenter randomized controlled trials examining the safety and efficacy of recombinant human BNP in HF patients is of major importance. 展开更多
关键词 Heart failure recombinant Brain natriuretic peptide OUTCOMES
下载PDF
Clinical observation of recombinant human nerve growth factor in the treatment of neurotrophic keratitis
7
作者 Mi Hao Yan Cheng +2 位作者 Jie Wu Yu Cheng Jing Wang 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2023年第1期60-66,共7页
AIM:To characterize changes of corneal nerve morphology and tear indices in patients with neurotrophic keratitis(NK)treated with recombinant human nerve growth factor(rhNGF).METHODS:In a prospective observational stud... AIM:To characterize changes of corneal nerve morphology and tear indices in patients with neurotrophic keratitis(NK)treated with recombinant human nerve growth factor(rhNGF).METHODS:In a prospective observational study,six patients(nine eyes)were locally treated with rhNGF.Visual acuity,corneal fluorescein staining score,the heights of the tear river,lipid layer thickness(LLT),tear ferning(TF)test,conjunctival impression cytology(CIC)examination,the densities of cornea subbasal nerve fibers were determined before and after treatment.RESULTS:Compared with baseline,there was a significant difference in corneal fluorescence staining scores(P<0.01);all patient corneal epithelial defects recovered completely within 8wk,but there was no significant improvement in the height of the tear river(P=0.202).LLT was significantly increased when compared with baseline(P=0.042);however,the function of conjunctival goblet cells and mucin content did not significantly improve using the TF test and CIC examination(P=0.557,P=0.539).After 8wk of treatment,the average corneal subbasal nerve fiber density increased significantly(P<0.01),as did the number of corneal nerve fiber branches(P=0.001).CONCLUSION:RhNGF can increase the density of corneal subbasal nerve fibers,promote the healing of persistent corneal epithelial defects and corneal ulcers in patients with NK,also improving tear function partially. 展开更多
关键词 recombinant human nerve growth factor neurotrophic keratitis corneal subbasal nerve
原文传递
重组木聚糖酶的高密度发酵及其定向制备低聚木糖
8
作者 赵剑 解静聪 +3 位作者 姜越 杨静 徐浩 张宁 《林产化学与工业》 CAS CSCD 北大核心 2024年第1期97-104,共8页
为提高酶水解杨木木聚糖定向转化低聚木糖的效率,同时降低酶法制备低聚木糖的成本,围绕重组大肠杆菌(PET-PdoXyn10A-DE3)高密度发酵制备拟杆菌来源木聚糖酶PdoXyn10A的诱导表达条件和酶水解制备低聚木糖的工艺条件开展了研究。考察了在... 为提高酶水解杨木木聚糖定向转化低聚木糖的效率,同时降低酶法制备低聚木糖的成本,围绕重组大肠杆菌(PET-PdoXyn10A-DE3)高密度发酵制备拟杆菌来源木聚糖酶PdoXyn10A的诱导表达条件和酶水解制备低聚木糖的工艺条件开展了研究。考察了在5 L发酵罐水平下诱导剂浓度、诱导光密度(OD_(600))值、诱导温度和诱导pH值等因素对PET-PdoXyn10A-DE3产重组木聚糖酶PdoXyn10A的影响,反应温度、pH值对玉米芯木聚糖酶水解过程中酶活力的影响,以及酶添加量、酶水解时间对杨木乙酸水解液制备低聚木糖的影响。研究结果表明:在诱导剂浓度0.25 mmol/L、诱导OD_(600)值55、诱导温度34℃和诱导pH值7.0的最佳诱导条件下,经高密度发酵重组酶酶活力可达362.67 U/mL,重组大肠杆菌生物量可达28.83 g/L。酶水解制备低聚木糖的最佳条件为酶反应温度40℃、pH值5.2、酶添加量12 U/mL和反应时间6 h,此条件下低聚木糖的量为3.21 g/L,其中木二糖、木三糖、木四糖、木五糖和木六糖的量分别为1.09、 0.97、 0.84、 0.18、 0.13 g/L,木糖为1.82 g/L。 展开更多
关键词 重组木聚糖酶 高密度发酵 乙酸水热反应 低聚木糖 酶水解条件
下载PDF
Overview of Recombinant Skin Models and Progress in Their Application in Vitro Assessment of Toxicity and Efficacy
9
作者 Zhang Bowen Xu Qiufeng +5 位作者 GU Wu Zhang Zhichun Dai Yumeng Han Zhiyang Xu Mingkai Wang Yu 《China Detergent & Cosmetics》 2023年第1期38-44,共7页
A recombinant skin model is a model in which skin cells are grown in vitro on a bioactive scaffold and provided with adequate nutrition to promote cell proliferation and differentiation to produce a mock skin structur... A recombinant skin model is a model in which skin cells are grown in vitro on a bioactive scaffold and provided with adequate nutrition to promote cell proliferation and differentiation to produce a mock skin structure and biological features. The development of recombinant skin models allows for effective and scientifically sound in vitro evaluation tests. This review briefly summarizes the overview of recombinant skin models and the progress of their application in in vitro evaluation which focuses on three aspects: skin irritation, skin corrosivity, and anti-skin aging. Moreover, an outlook on the future development of recombinant skin models is also provided in this review. 展开更多
关键词 recombinant skin model in vitro evaluation IRRITATION corrosiveness anti-skin aging
下载PDF
非洲猪瘟基因Ⅰ型/Ⅱ型重组病毒研究现状及思考
10
作者 戈胜强 沙洲 +7 位作者 郑辉 刘春菊 左媛媛 胡永新 王晓华 刘爽 魏荣 王志亮 《中国动物检疫》 CAS 2024年第3期68-72,共5页
基因重组在非洲猪瘟病毒(ASFV)基因组间广泛存在,它是造成ASFV遗传多样性的原因之一。ASFV基因Ⅱ型毒株2018年传入我国,2021年国内又报道发现基因Ⅰ型毒株和基因Ⅰ型/Ⅱ型重组病毒。我国分离的ASFV基因Ⅰ型/Ⅱ型重组毒嵌合了两个基因型... 基因重组在非洲猪瘟病毒(ASFV)基因组间广泛存在,它是造成ASFV遗传多样性的原因之一。ASFV基因Ⅱ型毒株2018年传入我国,2021年国内又报道发现基因Ⅰ型毒株和基因Ⅰ型/Ⅱ型重组病毒。我国分离的ASFV基因Ⅰ型/Ⅱ型重组毒嵌合了两个基因型序列并部分整合了二者的生物学特性,毒力与基因Ⅱ型强毒株相当,某些致病指标甚至更高;基因Ⅱ型减毒活疫苗株不能对该重组毒株产生有效保护。该重组毒株在国内的流行演变可能会显著影响ASFV的进化方向,并对ASFV疫苗研究带来新的挑战。本文通过对国内ASFV基因Ⅰ型/Ⅱ型重组病毒进行综述,就相关研究进展进行总结归纳,以期为我国ASF防控提供参考。 展开更多
关键词 非洲猪瘟 重组病毒 疫苗研发
下载PDF
对比罗沙司他与重组人促红细胞生成素对维持性血液透析患者冠状动脉钙化的影响
11
作者 文杨 夏运风 +2 位作者 甘华 李正荣 龚颖 《中国药房》 CAS 北大核心 2024年第5期590-594,共5页
目的对比罗沙司他与重组人促红细胞生成素(rHuEPO)对维持性血液透析(MHD)患者冠状动脉钙化的影响。方法采用回顾性分析的方法,选取重庆医科大学附属第一医院血液净化中心2019年4月至2021年6月处方中含罗沙司他的56例MHD患者作为ROX组,... 目的对比罗沙司他与重组人促红细胞生成素(rHuEPO)对维持性血液透析(MHD)患者冠状动脉钙化的影响。方法采用回顾性分析的方法,选取重庆医科大学附属第一医院血液净化中心2019年4月至2021年6月处方中含罗沙司他的56例MHD患者作为ROX组,同期处方中含rHuEPO的60例MHD患者作为EPO组,随访观察12个月,比较两组患者治疗前后实验室检查指标、冠状动脉钙化积分(CACS)、心脏超声参数的差异及随访期间心脑血管事件发生情况。结果治疗前及治疗后两组患者的CACS比较,差异均无统计学意义(P>0.05);但ROX组患者治疗前后的CACS差值明显低于EPO组患者(P<0.05)。两组患者治疗前后心脏超声参数及实验室检查指标比较,差异均无统计学意义(P>0.05)。随访期间,ROX组患者的脑卒中和心肌梗死发生率显著低于EPO组(P<0.05),但两组间因心衰住院的发生率差异无统计学意义(P>0.05)。结论与rHuEPO比较,罗沙司他可能对延缓MHD患者冠状动脉钙化有积极作用,且可能有利于减少MHD患者心肌梗死、脑卒中的发生。 展开更多
关键词 罗沙司他 重组人促红细胞生成素 维持性血液透析 冠状动脉钙化
下载PDF
钙钛矿太阳能电池材料缺陷对器件性能与稳定性的影响
12
作者 王静 高姗 +1 位作者 段香梅 尹万健 《物理学报》 SCIE EI CAS CSCD 北大核心 2024年第6期16-33,共18页
基于钙钛矿太阳能电池材料独特的光电特性,特别是光电转换效率在初期短时间内的快速提升,使其成为当前光伏领域中最富吸引力的光吸收材料之一.然而,近年来转换效率的增长步入缓慢阶段,同时材料的长期稳定性也成为商业化应用的关键挑战,... 基于钙钛矿太阳能电池材料独特的光电特性,特别是光电转换效率在初期短时间内的快速提升,使其成为当前光伏领域中最富吸引力的光吸收材料之一.然而,近年来转换效率的增长步入缓慢阶段,同时材料的长期稳定性也成为商业化应用的关键挑战,这些问题背后的物理机制与材料缺陷密切相关.为进一步提高电池效率和结构稳定性,必须深刻理解和精准地掌握这些缺陷的特性.本文全面回顾了钙钛矿材料中各类缺陷对光伏性能和稳定性的影响,包括传统刚性模型缺陷、非常规性缺陷、复合型缺陷、离子迁移和缺陷对载流子寿命的影响,论述了缺陷与材料结构稳定性之间的紧密关联性,并对未来关于缺陷的研究方向进行了展望. 展开更多
关键词 钙钛矿太阳能电池 缺陷 非辐射复合 稳定性
下载PDF
技术多元化能够促进企业绩效提升吗--技术重组模式与科学知识搜索的调节作用
13
作者 黄灿 徐戈 《科技进步与对策》 北大核心 2024年第2期108-118,共11页
技术多元化是企业获取竞争优势的关键,对于其如何影响企业绩效这一问题,学界存在不同观点。解决跨领域技术融合难题是企业从技术多元化战略中获益的关键,然而现有文献忽略了不同企业技术重组搜索特征差异,对于如何优化技术重组搜索过程... 技术多元化是企业获取竞争优势的关键,对于其如何影响企业绩效这一问题,学界存在不同观点。解决跨领域技术融合难题是企业从技术多元化战略中获益的关键,然而现有文献忽略了不同企业技术重组搜索特征差异,对于如何优化技术重组搜索过程以提升技术多元化战略实施效果这一问题尚未提供答案。从技术重组搜索视角出发,探究企业技术重组模式、科学知识搜索对技术多元化与企业绩效关系的调节作用。基于我国高技术产业上市公司面板数据的实证研究发现:技术多元化与企业绩效呈倒U型关系;技术重组创造促使该倒U型关系曲线变得平坦,技术重组再利用促使该倒U型关系曲线变得陡峭;科学知识搜索强度的调节作用不显著,但在企业科学知识搜索强度较高且擅长技术重组创造的情况下,技术多元化与绩效正相关,从而将“技术多元化陷阱”转变为“技术多元化优势”。随着技术多元化程度加深,企业不仅可以通过积累资源,而且能够通过优化技术重组过程,由技术重组再利用模式向技术重组创造模式转变,并通过加强科学知识搜索运用从技术多元化战略中获益。 展开更多
关键词 技术多元化 技术重组创造 技术重组再利用 科学知识搜索
下载PDF
木聚糖酶对育肥猪生长性能、血清生化指标及肠道形态的影响
14
作者 李俊 吴晗 《中国饲料》 北大核心 2024年第6期22-25,共4页
本研究旨在探究日粮中添加木聚糖酶对育肥猪生长性能、血清生化指标及肠道形态的影响。试验将120头平均体重(61±0.71)kg的三元育肥猪随机分为4组,每组5个重复,每个重复6头。饲喂玉米-豆粕型日粮,分别向基础日粮中添加0、200、400、... 本研究旨在探究日粮中添加木聚糖酶对育肥猪生长性能、血清生化指标及肠道形态的影响。试验将120头平均体重(61±0.71)kg的三元育肥猪随机分为4组,每组5个重复,每个重复6头。饲喂玉米-豆粕型日粮,分别向基础日粮中添加0、200、400、800 mg/kg的木聚糖酶。试验结果表明:日粮添加木聚糖酶显著提高育肥猪终末体重(P<0.05),日粮添加400和800 mg/kg木聚糖酶显著提高育肥猪平均日增重(P<0.05);日粮添加800 mg/kg木聚糖酶显著降低育肥猪料重比(P<0.05)。此外,日粮中添加木聚糖酶对育肥猪平均日采食量无显著影响(P>0.05)。日粮添加400 mg/kg木聚糖酶可显著提高育肥猪血清白蛋白、球蛋白和总蛋白含量(P<0.05);日粮添加800 mg/kg木聚糖酶可显著降低育肥猪血清尿素氮含量(P<0.05);日粮添加木聚糖酶对育肥猪血清谷草转氨酶、谷丙转氨酶、碱性磷酸酶、甘油三酯和总胆固醇含量无显著影响(P>0.05)。饲料添加木聚糖酶可显著提高育肥猪十二指肠和回肠绒毛高度和V/C值(P<0.05);此外,日粮添加木聚糖酶对育肥猪十二指肠、空肠和回肠的隐窝深度均无显著影响(P>0.05)。总之,本试验结果表明,育肥猪日粮木聚糖酶最适添加量为800 mg/kg。 展开更多
关键词 木聚糖酶 育肥猪 生长性能 血清生化指标 肠道形态
下载PDF
鼠疫耶尔森菌低钙应答V抗原人源单克隆抗体筛选与鉴定
15
作者 张黎 郑滨洋 +5 位作者 张琪 吴海莲 潘红星 朱凤才 吴海生 周剑芳 《中国人兽共患病学报》 CAS CSCD 北大核心 2024年第1期15-20,共6页
目的筛选抗低钙应答V抗原(LcrV)的人源单克隆抗体,分析抗体基因特点,检测抗体与抗原结合的特异性、亲和力及功能。方法使用PCR方法从鼠疫疫苗临床试验志愿者外周血细胞cDNA扩增抗体轻、重链可变区基因片段,构建ScFv噬菌体抗体文库。用L... 目的筛选抗低钙应答V抗原(LcrV)的人源单克隆抗体,分析抗体基因特点,检测抗体与抗原结合的特异性、亲和力及功能。方法使用PCR方法从鼠疫疫苗临床试验志愿者外周血细胞cDNA扩增抗体轻、重链可变区基因片段,构建ScFv噬菌体抗体文库。用LcrV对文库进行富集筛选,将获得的抗体基因表达成人IgG1后,测定抗体与LcrV抗原结合的特异性、亲和力、免疫调节功能以及保护能力。结果成功构建了鼠疫耶尔森菌人源ScFv抗体文库,库容量为7.54×10^(8)。抗体文库经LcrV筛选后获得了3株抗LcrV抗体,命名为RV-B4、RV-D1和RV-E8。3株抗体重链为VH1-46和VH3-30,轻链分别为VL1-51、VK3-20和VK1-39。3株抗体经ELISA及Western blot验证均与LcrV特异性结合,其与V抗原结合的解离常数(KD)分别为2.1 nmol/L、1.24 nmol/L和42 nmol/L。RV-D1体外降低人THP-1分泌TNF-α,动物攻毒试验中未发现抗LcrV抗体的保护效果。结论从鼠疫疫苗免疫人群获得了靶向低钙应答V抗原的人源抗体,以结合抗体为主,不能有效阻断病菌感染。所获得的单抗为鼠疫免疫基础研究、鼠疫诊断应用提供了候选材料。 展开更多
关键词 鼠疫耶尔森菌 低钙应答V抗原 噬菌体展示 重组抗体 保护效果
下载PDF
密码子优化的RHDV2双VP60基因重组杆状病毒构建及表达蛋白免疫原性分析
16
作者 于吉锋 谢晶 +8 位作者 黄勇 肖璐 林毅 曹冶 叶勇刚 魏勇 吴学婧 李江凌 康润敏 《中国畜牧兽医》 CAS CSCD 北大核心 2024年第2期668-677,共10页
[目的]试验旨在优化兔出血症病毒2型(Rabbit hemorrhagic disease virus 2,RHDV2)病毒样颗粒(virus-like particle, VLP)疫苗的制备策略,探究RHDV2 VLP疫苗对家兔的免疫原性,为低成本、高产量RHDV2新型疫苗研发提供新思路。[方法]根据... [目的]试验旨在优化兔出血症病毒2型(Rabbit hemorrhagic disease virus 2,RHDV2)病毒样颗粒(virus-like particle, VLP)疫苗的制备策略,探究RHDV2 VLP疫苗对家兔的免疫原性,为低成本、高产量RHDV2新型疫苗研发提供新思路。[方法]根据昆虫细胞的密码子偏好性优化合成RHDV2 VP60全基因,将双VP60基因插入真核载体pFastBacTMDual,转化携带Bacmid质粒的大肠杆菌DH10Bac感受态细胞,构建含双VP60基因的重组杆粒Bacmid-VP60-VP60,转染Sf9昆虫细胞,通过Western blotting、间接免疫荧光试验(IFA)及透射电镜对重组杆状病毒Bacmid-VP60-VP60进行表达验证;将优化策略制备的重组蛋白抗原与氢氧化铝佐剂按照9∶1比例制备VLP灭活疫苗,通过安全性检验、最小免疫剂量、免疫持续期等评估优化策略制备的RHDV2 VLP疫苗的保护效果。[结果]试验成功构建重组杆粒Bacmid-VP60-VP60。Western blotting鉴定结果显示,重组杆状病毒转染Sf9细胞表达出大小约60 ku的RHDV2 VP60蛋白。IFA鉴定结果显示,感染重组杆状病毒的Sf9细胞产生了大量的黄绿色荧光,表明重组杆状病毒在Sf9细胞中大量表达VP60蛋白。透射电镜观察结果显示,VP60蛋白折叠成VLP,大小为40 nm左右,呈现球形结构,表面光滑。优化策略制备的RHDV2 VLP疫苗对家兔具有良好的安全性和免疫原性,最小免疫剂量为0.5 mL/只,免疫持续期可达210 d以上。[结论]试验构建了含有密码子优化的双VP60基因的重组杆状病毒,并在昆虫细胞中成功表达RHDV2 VP60蛋白,该蛋白制备的VLP疫苗对家兔具有良好的免疫原性。 展开更多
关键词 兔出血症病毒2型(RHDV2) 病毒样颗粒(VLP) 密码子偏好性 重组杆状病毒 免疫原性
下载PDF
泄浊养血法联合重组人促红素注射液治疗肾虚湿浊型慢性肾脏病3~5期肾性贫血患者的临床观察
17
作者 张婧 杨思齐 +2 位作者 韩玉 赵晰 王耀光 《天津中医药》 CAS 2024年第3期281-286,共6页
[目的]观察泄浊养血法联合重组人促红素注射液对慢性肾脏病(CKD)3~5期肾性贫血患者贫血改善及残余肾功能的干预作用。[方法]选择2020年10月—2021年10月就诊于天津中医药大学第一附属医院的88例CKD 3~5期肾性贫血患者,根据随机数字表法... [目的]观察泄浊养血法联合重组人促红素注射液对慢性肾脏病(CKD)3~5期肾性贫血患者贫血改善及残余肾功能的干预作用。[方法]选择2020年10月—2021年10月就诊于天津中医药大学第一附属医院的88例CKD 3~5期肾性贫血患者,根据随机数字表法随机分为对照组(44例)和治疗组(44例)。对照组予重组人促红细胞生成素注射液及多糖铁复合物治疗,治疗组在此基础上联合泄浊养血法中药方治疗,连续服用3个月,观察治疗前后两组临床疗效、红细胞计数(RBC)、血红蛋白(Hb)、血清肌酐(Scr)、尿素氮(BUN)、肾小球滤过率(eGFR)、尿微量白蛋白(mALB)、丙氨酸氨基转移酶(ALT)、天门冬氨酸氨基转移酶(AST)的变化,症状积分及不良反应发生率。[结果]治疗3个月后,治疗组总有效率为86.36%,对照组为56.82%,治疗组临床疗效优于对照组(P<0.05);症状积分、RBC、Hb、Scr、BUN、mALB均较治疗前改善,且治疗组优于对照组(P<0.05);安全性指标中AST、ALT治疗前后数值变化,差异无统计学意义(P>0.05)。两组病例中均未出现不良反应。[结论]泄浊养血法联合重组人促红细胞生成素注射液治疗可以改善CKD 3~5期非透析肾性贫血患者临床症状,提高临床疗效,延缓肾功能进展,且具有一定的安全性。 展开更多
关键词 肾性贫血 泄浊养血方 重组人促红素注射液 CKD 3~5期
下载PDF
2018年盐城市CVA6型肠道病毒全基因组分子特征分析
18
作者 王瑶 陈国清 +4 位作者 薛宇铭 安然 李长城 徐士林 李春香 《江苏预防医学》 CAS 2024年第1期73-76,99,共5页
目的掌握盐城市肠道病毒CVA6型基因进化特征。方法对盐城市鉴定为CVA6型的肠道病毒,通过反转录聚合酶链式反应的方法扩增全基因组序列,扩增产物经纯化测序,采用相应的生物信息软件进行核苷酸及氨基酸序列比对、分子进化树构建以及重组... 目的掌握盐城市肠道病毒CVA6型基因进化特征。方法对盐城市鉴定为CVA6型的肠道病毒,通过反转录聚合酶链式反应的方法扩增全基因组序列,扩增产物经纯化测序,采用相应的生物信息软件进行核苷酸及氨基酸序列比对、分子进化树构建以及重组分析。结果盐城市2018年共检测疑似疱疹性咽峡炎病例107例,肠道病毒核酸阳性率73.83%,其中CVA6、CVA16、其他肠道病毒分别占50.63%、5.06%、44.30%,未检出EV71。选取3株2018年疱疹性咽峡炎、3株2018年手足口病(流行月峰前、峰中、峰后)、1株2017年手足口病CVA6型代表株进行全基因组测序,遗传进化树显示:7株盐城株位于B进化分支B2基因亚群分支,3株疱疹性咽峡炎CVA6型代表株与2株2018年手足口病CVA6型毒株聚集成簇构成一进化小分支,2株手足口病毒株(2017年、2018年各1株)形成独立的进化小分支,形成2条传播链。选取2个进化小分支中疱疹性咽峡炎、手足口病CVA6型各1株,进行分子进化重组分析,均未发现明显的重组来源。结论2018年盐城市疱疹性咽峡炎的病原谱呈现遗传多样性,CVA6型肠道病毒为优势流行株,与手足口病的CVA6型肠道病毒可能有着共同的来源,盐城株未发现基因重组。 展开更多
关键词 柯萨奇病毒A6型 疱疹性咽峡炎 手足口病 全基因组序列 基因重组
下载PDF
青春期矮身材儿童身高改善的药物治疗
19
作者 朱建芳 王春林 《中国当代儿科杂志》 CAS CSCD 北大核心 2024年第2期118-123,共6页
青春期矮身材可严重影响青少年的身心健康。青春期由于性激素导致的骨龄持续加速进展,限制了生长所需的时间,是矮身材治疗的巨大挑战,至今仍无标准化的治疗方案。青春期也是改善成年终身高的最后机会。目前临床常用治疗药物主要有重组... 青春期矮身材可严重影响青少年的身心健康。青春期由于性激素导致的骨龄持续加速进展,限制了生长所需的时间,是矮身材治疗的巨大挑战,至今仍无标准化的治疗方案。青春期也是改善成年终身高的最后机会。目前临床常用治疗药物主要有重组人生长激素、促性腺激素释放激素类似物和第三代芳香化酶抑制剂。近年来,以改善成年终身高为目的的个体化治疗成为临床关注的重点。该文对青春期矮身材儿童身高改善的药物治疗相关研究进行梳理总结,为临床医生提供参考. 展开更多
关键词 矮身材 重组人生长激素 促性腺激素释放激素类似物 芳香化酶抑制剂 青春期
下载PDF
微针导入重组Ⅲ型人源化胶原蛋白在皮肤屏障功能修复中的应用效果
20
作者 于文渊 耿栋芸 +3 位作者 庄卉如 陆蒋惠文 邱丹丹 赵天兰 《临床医学研究与实践》 2024年第7期102-105,共4页
目的探究微针导入重组Ⅲ型人源化胶原蛋白治疗因皮肤炎性衰老导致的皮肤屏障功能下降的有效性及安全性。方法选取2020年6月至2021年5月在本院接受面部皮肤治疗的30例患者作为研究对象,采用随机数字表法将其分为对照组(重组Ⅲ型人源化胶... 目的探究微针导入重组Ⅲ型人源化胶原蛋白治疗因皮肤炎性衰老导致的皮肤屏障功能下降的有效性及安全性。方法选取2020年6月至2021年5月在本院接受面部皮肤治疗的30例患者作为研究对象,采用随机数字表法将其分为对照组(重组Ⅲ型人源化胶原蛋白)与治疗组(微针导入重组Ⅲ型人源化胶原蛋白),各15例。治疗后定期对患者进行随访,分别进行主观疗效评价及客观疗效评价。结果治疗后4、8、12周,治疗组的满意度显著高于对照组(P<0.05)。治疗后,治疗组的皮肤皱纹、纹理、红区、毛孔、弹性、皮肤经皮失水及皮肤含水量改善明显(P<0.05);对照组治疗后油脂改善明显(P<0.05)。治疗后12周,治疗组的总症状评分显著低于对照组(P<0.05)。结论微针导入重组Ⅲ型人源化胶原蛋白对皮肤修复有较好的疗效,可增强皮肤屏障功能,为改善皮肤屏障功能、治疗因皮肤屏障受损引起的炎性衰老提供了新选择。 展开更多
关键词 微针 重组Ⅲ型人源化胶原蛋白 炎性衰老 皮肤屏障功能
下载PDF
上一页 1 2 250 下一页 到第
使用帮助 返回顶部